PET imaging was performed to examine the biodistribution and pharmacokinetic properties of 64Cu-DOTA-anti-CTLA-4 mAb, and the data showed a significantly higher accumulation in the tumor [31]. The gene discussed is CTLA4; the disease is neoplasm.